Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals disclosed inducement grants to 12 new employees under Nasdaq Listing Rule 5635(c)(4). The awards consist of 22,950 non-qualified stock options and 31,300 restricted stock units, granted on May 11, 2026.
Key figures
- Rsus granted
- 31300
- Options granted
- 22950
- New employees hired
- 12
- Option exercise price
- 106.17
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.